Clinical Trial Update: Study of Oral Bisphosphonate for Osteopenic Women Treated With Adjuvant Aromatase Inhibitors [Phase 2]

View source ↗

Summary

Phase 2 trial assessing an oral bisphosphonate for osteopenic women treated with adjuvant aromatase inhibitors in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• oral bisphosphonate

Snippet

Sponsor: Azienda Ospedaliero-Universitaria Careggi | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED